NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
01/24/2023
Back to search
Official data from USPTO
DESIGNPHARMA
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
16
Latest update
01/24/2023
Trademark type
Combined
Nice classes
42
Filing date
06/16/2021
Registration date
01/24/2023
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
01/24/2023
Last transaction
01/24/2023
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
3
Owner type
99
Owner location
Cambridge, MA
Examiner
HAN, JOANNA
Law office
N80
Current location
PUBLICATION AND ISSUE SECTION
Mark description
The mark consists of the stylized words "DESIGNPHARMA" with the wording "DESIGN" in aqua and the wording "PHARMA" in black; to the left of the stylized wording is a design comprised of an outline of a diamond shape with different colors for each side, aqua, blue, green and red.
Holders and representatives
Holders
Biomillenia SAS
Representatives
Lynn E. Rzonca BALLARD SPAHR LLP
Technical classification
Nice Classes
Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 42
Drug discovery services; biological research and clinical research in the medicalpharmaceuticalbiotechnology fields; medical research; research on the subject of pharmaceuticals; scientific research for medical purposes in the area of cancerous diseases; research and development in the pharmaceutical and biotechnology fields; research and development in the pharmaceutical and biotechnology fields for the pharmaceutical industry; pharmaceutical products development; medical laboratory services relating to the production of monoclonal antibodies; biomedical research services; medical and scientific research in the field of pharmacogenetics; research and development of vaccines and medicines; pharmaceutical drug development services; development of pharmaceutical preparations and medicines; consulting services in the field research and developmentresearch and development of pharmaceutical therapeutics; consultancy relating to research and development in the field of therapeutics; pharmaceutical research services
Publications
History of USPTO decisions and trademark events.
16 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
01/24/2023
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
11/08/2022
PUBO
PUBLISHED FOR OPPOSITION
11/08/2022
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
10/19/2022
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
10/06/2022
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
09/12/2022
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
09/12/2022
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
09/12/2022
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
03/11/2022
GNRT
NON-FINAL ACTION E-MAILED
03/11/2022
CNRT
NON-FINAL ACTION WRITTEN
03/11/2022
DOCK
ASSIGNED TO EXAMINER
03/07/2022
MDSM
NOTICE OF DESIGN SEARCH CODE E-MAILED
09/03/2021
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
09/02/2021
NWAP
NEW APPLICATION ENTERED
06/19/2021
Continuous trademark protection
Get notified about every new filing that threatens DESIGNPHARMA or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.